Microarray analysis of MCF-7 breast cancer cells treated with 1,25-dihydroxyvitamin D3 or a 17-methyl-D-ring analog

Anticancer Research

Volumn 29, Issue 9, 2009, Pages 3585-3590

  Vanoirbeek, Els ^a   Eelen, Guy ^a   Verlinden, Lieve ^a   Marchal, Kathleen ^a   Engelen, Kristof ^a   De Moor, Bart ^a   Beullens, Ine ^a   Marcelis, Suzanne ^a   De Clercq, Pierre ^b   Bouillon, Roger ^a   Verstuyf, Annemieke ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c Onderwijs en Navorsing   (Belgium)

Author keywords

Analogs; Antiproliferative effect; Microarray; Non steroidal; Vitamin D

Indexed keywords

CALCITRIOL; CALCITRIOL DERIVATIVE; RNA; UNCLASSIFIED DRUG; WY 1112;

CELL STRAIN MCF 7; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACTIVITY; GENE INDUCTION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; RNA ANALYSIS;

BREAST NEOPLASMS; CALCITRIOL; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 68549118799     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Okano T, Yasumura M, Mizuno K, and Kobayashi T: Photochemical conversion of 7-dehydrocholesterol into vitamin D3 in rat skins. J Nutr Sci Vitaminol 23: 165-168, 1977. (Pubitemid 8110835)
2. Holick MF: The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol 77: 51-58, 1981.
3. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P and Evans RM: The nuclear receptor superfamily: the second decade. Cell 83: 835-839, 1995. (Pubitemid 126663112)
4. Kliewer SA, Umemoso K, Mangelsdorf DJ and Evans RM: Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D signaling. Nature 355: 446-449, 1992.
5. Kimmel-Jehan C, Darwish HM, Strugnell SA, Jehan F, Wiefling B and DeLuca HF: DNA bending is induced by binding of vitamin D receptor-retinoid X receptor heterodimers to vitamin D response elements. J Cell Biochem 74: 220-228, 1999. (Pubitemid 29307712)
6. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE and Jurutka PW: The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13: 325-349, 1998.
7. Eelen G, Gysemans C, Verlinden L, Vanoirbeek E, De Clercq P, Van Haver D, Mathieu C, Bouillon R and Verstuyf A: Mechanism and potential of the growth-inhibitory actions of vitamin D and analogs. Curr Med Chem 14(17): 1893-1910, 2007.
8. Verstuyf A, Verlinden L, van Etten E, Shi L, Wu Y, D'Halleweyn C, Van Haver D, Zhu GD, Chen YJ, Zhou X, Haussler MR, De Clercq P, Vandewalle M, Van Baelen H, Mathieu C and Bouillon R: Biological activity of CD-ring modified 1α,25-dihydroxyvitamin D analogues: C-ring and five-membered D-ring analogues. J Bone Miner Res 2: 237-252, 2000. (Pubitemid 30095710)
9. 3 in target cells. J Nutr Sci Vitaminol (Tokyo), pp. 75-78, 1992.
10. Mäenpää PH, Väisänen S, Jääskelä inen T, Ryhänen S, Rouvinen J, Duchier C and Mahonen A: Vitamin D(3) analogs (MC 1288, KH 1060, EB 1089, GS 1558, and CB 1093): studies on their mechanism of action. Steroids 66(3-5): 223-225, 2001. (Pubitemid 32140899)
11. Towsend K, Trevino V, Falciani F, Stewart PM, Hewison M and Campbell MJ: Identification of VDR-responsive gene signatures in breast cancer cells. Oncology 71(1-2): 111-123, 2006.
12. Swami S, Raghavachari N, Muller UR, Bao YP and Feldman D: Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Res Treat 80(7): 49-62, 2003. (Pubitemid 36851284)
13. 3 suppresses the androgen-stimulated growth of mouse mammary carcinoma SC-3 cells by transcriptional repression of fibroblast growth factor 8. J Cell Physiol 207(3): 793-799, 2006. (Pubitemid 43668244)
14. Lee HJ, Liu H, Goodman C, Ji Y, Maehr H, Uskokovic M, Notterman D, Reiss M and Suh N: Gene expression profiling changes induced by a novel gemini vitamin D derivative during the progression of breast cancer. Biochem Pharmacol 72(3): 332-343, 2006. (Pubitemid 43975086)
15. 3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol Endocrinol 16(6): 1243-1256, 2002. (Pubitemid 34621073)
16. 3 and its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells. Mol Endocrinol 15(7): 1127-1139, 2001. (Pubitemid 32614067)
17. Eelen G, Verlinden L, Rochel N, Ciaessens F, De Clercq P, Vandewalle M, Tocchini-Valentini G, Moras D, Bouillon R and Verstuyf A: Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction. Mol Pharmacol 67(5): 1566-1573, 2005. (Pubitemid 40594155)
18. Eelen G, Verlinden L, Van Camp M, Claessens F, De Clercq P, Vandewalle M, Bouillon R and Verstuyf A: Altered vitamin D receptor-coactivator interactions reflect superagonism of vitamin D analogs. J Steroid Biochem Mol Biol 97(1-2): 65-68, 2005. (Pubitemid 41546215)